Intelligence · Clinical Development
Pipeline search results
Programs matching “loncastuximab tesirine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 13 pipeline programs matching "loncastuximab tesirine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Loncastuximab Tesirine
ADC Therapeutics SA
Relapsed Diffuse Large B-Cell Lymphoma
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
Relapsed or Refractory Large B-cell Lymphoma
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
Waldenstrom Macroglobulinemia
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
Diffuse Large B-cell Lymphoma
4 trials -
Loncastuximab Tesirine
ADC Therapeutics SA
Relapsed Follicular Lymphoma
1 trial -
Loncastuximab tesirine
ADC Therapeutics SA
Post-transplant Lymphoproliferative Disorder
1 trial -
Loncastuximab tesirine
ADC Therapeutics SA
Diffuse Large B-Cell Lymphoma Refractory
1 trial -
Loncastuximab tesirine
ADC Therapeutics SA
Follicular Lymphoma
1 trial -
Loncastuximab tesirine 150 µg/Kg
ADC Therapeutics SA
Marginal Zone Lymphoma
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
B-Cell Non-Hodgkin Lymphoma
1 trial -
Loncastuximab Tesirine and Acalabrutinib
ADC Therapeutics SA
Chronic Lymphocytic Leukemia
1 trial -
Loncastuximab Tesirine and Durvalumab
ADC Therapeutics SA
Diffuse Large B-Cell Lymphoma
1 trial -
Loncastuximab tesirine and rituximab (Lonca-R)
ADC Therapeutics SA
Central Nervous System Lymphoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.